拜新同与拉贝洛尔治疗早期妊娠合并高血压的临床效果观察

Observation on the Clinical Effect of Baixintong and Labetolol in the Treatment of Hypertension in Early Pregnancy

目的分析拜新同与拉贝洛尔治疗早期妊娠合并高血压的临床效果。方法选取2016年10月至2017年10月我院接收的80例早期妊娠合并高血压患者,将其随机分为观察组与对照组,各组40例,对照组采用拜新同治疗,观察组采用拜新同与拉贝洛尔治疗。将两组患者的治疗效果以及治疗后血压变化情况、不良反应等进行比较。结果观察组治疗总有效率高于对照组,且治疗后血压控制情况优于对照组(P<0.05);两组患者不良反应发生率均较低,组间比较(P>0.05)。结论采用拜新同与拉贝洛尔治疗早期妊娠合并高血压具有显著的疗效,其能有效地改善患者血压,且不良反应发生情况较少,值得进一步推广应用。

Objective To analyze the clinical effects of the treatment of hypertension in early pregnancy with Baixintong and Labetolol. Methods Eighty cases of early pregnancy with hypertensive patients received from our hospital from October 2016 to October 2017 were random Ly divided into the observation group and the control group. There were 40 cases in each group. The control group was treated with Baixintong and observed. The group used Baixintong and Labellol for treatment. The treatment effects of the two groups of patients were compared with changes in blood pressure and adverse reactions after treatment. Results The total effective rate in the observation group was higher than that in the control group, and the control of blood pressure after treatment was better than that in the control group（P〈0.05）. The incidence of adverse reactions was lower in the two groups and the comparison between the two groups（P〈0.05）. Conclusion The treatment of hypertension in early pregnancy with Baixintong and Labetalol has significant curative effect. It is worth further promotion and application.